Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Emerging Investigator Awardee
Emerging Investigator Awardee
Back

Kenneth Kalunian, MD,FACR

UC San Diego
La Jolla, CA, United States

Adult rheumatologist/clinical scientist with interests in SLE and OA.

Presentation(s):

  • Treatment of Lupus Arthritis in 2024

    Monday, November 18, 2024
    4:10 PM – 4:30 PM Eastern Time

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing); Amgen: Grant/Research Support (Ongoing); AstraZeneca: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); EquilliumBio: Consultant (Ongoing); Genentech: Consultant (Ongoing); Gilead: Consultant (Ongoing); Janssen: Consultant (Ongoing); KezarBio: Advisor or Review Panel Member (Ongoing); Merck/MSD: Consultant (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Remegene: Consultant (Ongoing); Roche: Consultant (Ongoing); UCB: Grant/Research Support (Ongoing)

  • 226: Defining a path to remission in Systemic Lupus Erythematosus (SLE)

    Monday, November 18, 2024
    5:45 PM – 7:45 PM Eastern Time

    Disclosure information not submitted.